PACS Group (NYSE:PACS – Get Free Report) is one of 233 public companies in the “Healthcare Providers & Services” industry, but how does it weigh in compared to its rivals? We will compare PACS Group to similar companies based on the strength of its valuation, profitability, analyst recommendations, dividends, earnings, institutional ownership and risk.
Valuation & Earnings
This table compares PACS Group and its rivals gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| PACS Group | $5.29 billion | $191.54 million | 28.32 |
| PACS Group Competitors | $21.55 billion | $301.67 million | 7.21 |
PACS Group’s rivals have higher revenue and earnings than PACS Group. PACS Group is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.
Risk & Volatility
PACS Group has a beta of -0.14, meaning that its stock price is 114% less volatile than the S&P 500. Comparatively, PACS Group’s rivals have a beta of 0.98, meaning that their average stock price is 2% less volatile than the S&P 500.
Insider and Institutional Ownership
56.7% of shares of all “Healthcare Providers & Services” companies are owned by institutional investors. 70.1% of PACS Group shares are owned by insiders. Comparatively, 15.0% of shares of all “Healthcare Providers & Services” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Profitability
This table compares PACS Group and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| PACS Group | 4.87% | 31.98% | 6.07% |
| PACS Group Competitors | -8.06% | -138.13% | -1.54% |
Analyst Ratings
This is a summary of recent ratings and recommmendations for PACS Group and its rivals, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| PACS Group | 0 | 1 | 7 | 0 | 2.88 |
| PACS Group Competitors | 1867 | 7741 | 13367 | 825 | 2.55 |
PACS Group currently has a consensus price target of $61.33, suggesting a potential upside of 22.36%. As a group, “Healthcare Providers & Services” companies have a potential upside of 12.66%. Given PACS Group’s stronger consensus rating and higher probable upside, equities research analysts clearly believe PACS Group is more favorable than its rivals.
Summary
PACS Group beats its rivals on 8 of the 13 factors compared.
About PACS Group
PACS Group, Inc. is a post-acute healthcare provider that operates skilled nursing and rehabilitation facilities. Its services include nursing care, physical and occupational therapy, and support for patients recovering from illness or injury, as well as care for people with ongoing or long-term needs. Founded in 2013, the company has expanded its network of facilities across the United States. Its operations are organized through affiliated entities, with care and services tailored to the needs of residents and patients in the communities it serves.
Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.
